# Prevention of Radiotherapy Induced Enteropathy by Probiotics (PREP)

> **NCT03978949** · PHASE3 · UNKNOWN · sponsor: **Asan Medical Center** · enrollment: 248 (estimated)

## Conditions studied

- Radiotherapy
- Toxicity
- Diarrhea
- Probiotics

## Interventions

- **DRUG:** Bacillus Licheniformis
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03978949
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-06-01
- **Primary completion:** 2021-08-31
- **Final completion:** 2024-08-31
- **Target enrollment:** 248 (ESTIMATED)
- **Last updated:** 2021-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03978949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03978949, "Prevention of Radiotherapy Induced Enteropathy by Probiotics (PREP)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT03978949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*